Vascular Endothelial Growth Factor (VEGF) in seizures: A double-edged sword

Advances in Experimental Medicine and Biology

Volumn 548, Issue , 2004, Pages 57-68

  Croll, Susan D ^a,b   Goodman, Jeffrey H ^c   Scharfman, Helen E ^c,d  

^a CITY UNIVERSITY OF NEW YORK   (United States)

^b REGENERON PHARMACEUTICALS INC   (United States)

^c HELEN HAYES HOSPITAL   (United States)

^d Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; NEUROPILIN 1; NEUROTROPHIC FACTOR; PILOCARPINE; PLACENTA PROTEIN; VASCULOTROPIN; VASCULOTROPIN A; VASCULOTROPIN B; VASCULOTROPIN C; VASCULOTROPIN D; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; BLOOD BRAIN BARRIER; BLOOD VESSEL PERMEABILITY; BRAIN EDEMA; BRAIN HYPOXIA; BRAIN ISCHEMIA; CELL ACTIVITY; CELL DAMAGE; CELL TYPE; EPILEPTIC STATE; GLIA; HIPPOCAMPUS; HUMAN; HYPOXIA; IMMUNOHISTOCHEMISTRY; INFLAMMATION; NERVE CELL; NERVE CELL NECROSIS; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RECEPTOR BINDING; REVIEW; SEIZURE; SPREADING CORTICAL DEPRESSION; UPREGULATION; VASCULAR ENDOTHELIUM; VASCULARIZATION;

EID: 3242808153     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4757-6376-8_4     Document Type: Review

References (110)

1. 125I-albumin. Stroke 1985; 16:101-109.
2. Hatashita S, Hoff JT. Role of blood-brain barrier permeability in focal ischemic brain edema. Adv Neurol 1990; 52:327-333.
3. Hatashita S, Hoff JT. Brain edema and cerebrovascular permeability during cerebral ischemia in rats. Stroke 1990; 21:582-588.
4. Nakagawa Y, Fujimoto N, Matsumoto K et al. Morphological changes in acute cerebral ischemia after occlusion and reperfusion in the rat. Adv Neurol 1990; 52:21-27.
5. Kitagawa K, Matsumoto M, Tagaya M et al. Temporal profile of serum albumin extravasation following cerebral ischemia in a newly established reproducible gerbil model for vasogenic brain edema: a combined immunohistochemical and dye tracer analysis. Acta Neuropathol (Berl) 1991; 82:164-171.
6. Menzies SA, Ben AL, Hoff JT. Contributions of ions and albumin to the formation and resolution of ischemic brain edema. J Neurosurg 1993; 78:257-266.
7. Matsumoto K, Lo EH, Pierce AR et al. Role of vasogenic edema and tissue cavitation in ischemic evolution on diffusion-weighted imaging: comparison with multiparameter MR and immunohistochemistry. Am J Neuroradiol 1995; 16:1107-1115.
8. Rosenberg GA. Ischemic brain edema. Prog Cardiovasc Dis 1999; 42:209-216.
9. Ates N, Esen N, Ilbay G. Absence epilepsy and regional blood-brain barrier permeability: the effects of pentylenetetrazole-induced convulsions. Pharmacol Res 1999; 39:305-310.
10. Cornford EM. Epilepsy and the blood brain barrier: endothelial cell responses to seizures. Adv Neurol 1999; 79:845-862.
11. Roch C, Leroy C, Nehlig A et al. Magnetic resonance imaging in the study of the lithium-pilocarpine model of temporal lobe epilepsy in adult rats. Epilepsia 2002; 43:325-335.
12. Feuerstein GZ, Wang X, Barone FC. Inflammatory gene expression in cerebral ischemia and trauma. Potential new therapeutic targets. Ann NY Acad Sci 1997; 825,179-193.
13. del Zoppo GJ, Wagner S, Tagaya M. Trends and future developments in the pharmacological treatment of acute ischaemic stroke. Drugs 1997; 54:9-38.
14. Becker KJ. Inflammation and acute stroke. Curr Opin Neurol 1998; 11:45-49.
15. DeGraba TJ. The role of inflammation after acute stroke: utility of pursuing anti-adhesion molecule therapy. Neurology 1998; 51:562-68.
16. Jean WC, Spellman SR, Nussbaum ES et al. Reperfusion injury after focal cerebral ischemia: the role of inflammation and the therapeutic horizon. Neurosurgery 1998; 43:1382-1396.
17. del Zoppo GJ, Hallenbeck JM. Advances in the vascular pathophysiology of ischemic stroke. Thromb Res 2000; 98:73-81.
18. Stanimirovic D, Satoh K. Inflammatory mediators of cerebral endothelium: a role in ischemic brain inflammation. Brain Pathol 2000; 10:3-126.
19. Zhang RL, Chopp M, Jiang N et al. Anti-intercellular adhesion molecule-1 antibody reduces ischemic cell damage after transient but not permanent middle cerebral artery occlusion in the Wistar rat. Stroke 1995; 26:1438-1442.
20. Chopp M, Li Y, Jiang N et al. Antibodies against adhesion molecules reduce apoptosis after transient middle cerebral artery occlusion in rat brain. J Cereb Blood Flow Metab 1996; 16:578-584.
21. Chopp M, Zhang ZG. Anti-adhesion molecule and nitric oxide protection strategies in ischemic stroke. Curr Opin Neurol 1996; 9:68-72.
22. Goussev AV, Zhang Z, Anderson DC et al. P-selectin antibody reduces hemorrhage and infarct volume resulting from MCA occlusion in the rat. J Neurol Sci 1998; 161:16-22.
23. Jiang N, Chopp M, Chahwala S. Neutrophil inhibitory factor treatment of focal cerebral ischemia in the rat. Brain Res 1998; 788:25-34.
24. Peltola J, Laaksonen J, Haapala AM et al. Indicators of inflammation after recent tonic-clonic epileptic seizures correlate with plasma interleukin-6 levels. Seizure 2002; 11:44-46.
25. Vezzani A, Conti M, De Luigi A et al. Interleukin-1beta immunoreactivity and microglia are enhanced in the rat hippocampus by focal kainate application: functional evidence for enhancement of electrographic seizures. J Neurosci 1999; 19:5054-5065.
26. De Simoni MG, Perego C, Ravizza T et al. Inflammatory cytokines and related genes are induced in the rat hippocampus by limbic status epilepticus. Eur J Neurosci 2000; 12:2623-2633.
27. Vezzani A, Moneta D, Conti M et al. Powerful anticonvulsant action of IL-1 receptor antagonist on intracerebral injection and astrocytic overexpression in mice. Proc Natl Acad Sci USA 2000; 97:11534-11539.
28. Vezzani A, Moneta D, Richichi C et al. Functional role of inflammatory cytokines and antiinflammatory molecules in seizures and epileptogenesis. Epilepsia 2002; 43(S5):30-35.
29. Tomanek RJ, Schatteman GC, Angiogenesis. New insights and therapeutic potential. Anat Rec 2000; 261:126-135.
30. Yancopoulos GD, Davis S, Gale NW et al. Vascular-specific growth factors and blood vessel formation. Nature 2000; 407:242-248.
31. Bednar MM, Raymond S, McAuliffe T et al. The role of neutrophils and platelets in a rabbit model of thromboembolic stroke. Stroke 1991; 22:44-50.
32. Clark RK, Lee EV, Fish CJ et al. Development of tissue damage, inflammation and resolution following stroke: an immunohistochemical and quantitative planimetric study. Brain Res Bull 1993; 31:565-572.
33. Morioka T, Kalehua AN, Streit WJ. Characterization of microglial reaction after middle cerebral artery occlusion in rat brain. J Comp Neurol 1993; 327:123-132.
34. Okada Y, Copeland BR, Mori E et al. P-selectin and intercellular adhesion molecule-1 expression after focal brain ischemia and reperfusion. Stroke 1994; 25:202-211.
35. Beck H, Acker T, Wiessner C et al. Expression of angiopoietin-1, angiopoietin-2 and tie receptors after middle cerebral artery occlusion in the rat. Amer J Pathol 2000; 157:1473-1483.
36. Marti HJ, Bernaudin M, Bellail A et al. Hypoxia-induced vascular endothelial growth factor expression precedes neovascularization after cerebral ischemia. Am J Pathol 2000; 156:965-976.
37. Schwab JM, Nguyen TD, Postler E et al. Selective accumulation of cyclooxygenase-1-expressing microglial cells/macrophages in lesions of human focal cerebral ischemia. Acta Neuropathol (Berl) 2000; 99:609-614.
38. Wang X, Yue TL, Barone FC et al. Demonstration of increased endothelial-leukocyte adhesion molecule-1 mRNA expression in rat ischemic cortex. Stroke 1995; 26:1665-1668.
39. Zubkov AY, Ogihara K, Bernanke DH et al. Apoptosis of endothelial cells in vessels affected by cerebral vasospasm. Surg Neurol 2000; 53:260-266.
40. Senger DR, Perruzzi CA, Feder J et al. A highly conserved vascular permeability factor secreted by a variety of human and rodent tumor cell lines. Cancer Res 1986; 46:5629-5632.
41. Frelin C, Ladoux A, D'Angelo G. Vascular endothelial growth factors and angiogenesis. Ann Endocrinol (Paris) 2000; 61:70-74.
42. Quinn TP, Peters KG, De Vries C et al. Fetal liver kinase 1 is a receptor for vascular endothelial growth factor and is selectively expressed in vascular endothelium. Proc Natl Acad Sci USA 1993; 90:7533-7537
43. Soker S, Takashima S, Miao H et al. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell 1998; 92:735-745.
44. Gluzman-Poltorak Z, Cohen T, Herzog Y et al. Neuropilin-2 and neuropilin-1 are receptors for the 165-amino acid form of vascular endothelial growth factor (VEGF) and of placenta growth factor-2, but only neuropilin-2 functions as a receptor for the 145-amino acid form of VEGF. Biol Chem 2000; 275:18040-5.
45. Jin KL, Mao XO, Greenberg DA. Vascular endothelial growth factor: direct neuroprotective effect in in vivo ischemia. Proc Natl Acad Sci 2000; 97:10242-10247.
46. Sondell M, Sundler F, Kanje M. Vascular endothelial growth factor is a neurotrophic factor which stimulates axonal outgrowth through the flk-1 receptor. Eur J Neurosci 2000; 12:4243-4254.
47. Croll SD, Wiegand SJ. Vascular growth factors and cerebral ischemia. Mol Neurobiol 2001; 23:121-35.
48. Krum JM, Mani N, Rosenstein JM. Angiogenic and astroglial responses to vascular endothelial growth factor administration in adult rat brain. Neuroscience 2002; 110:589-604.
49. Lennmyr F, Ata KA, Funa K et al. Expression of vascular endothelial growth factor (VEGF) and its receptors (Flt-1 and Flk-1) following permanent and transient occlusion of the middle cerebral artery in the rat. J Neuropathol Exp Neurol 1998; 57:874-882.
50. Sawano A, Iwai S, Sakurai Y et al. Flt-1, vascular endothelial growth factor receptor 1, is a novel cell surface marker for the lineage of monocyte-macrophages in humans. Blood 2001; 97:785-791.
51. Kawakami A, Kitsukawa T, Takagi S et al. Developmentally regulated expression of a cell surface protein, neuropilin, in the mouse nervous system. J Neurobiol 1996; 29:1-17.
52. Chédotal A, Del Rio JA, Ruiz M et al. Semaphorins III and IV repel hippocampal axons via two distinct receptors. Develop 1998; 125:4313-4323.
53. Ferrara N, Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr Rev 1997; 18:4-25.
54. Carmeliet P, Collen D. Molecular basis of angiogenesis. Roles of VEGF and VE-cadherin. Ann NY Acad Sci 2000; 902, 249-262.
55. Dvorak HF. VPF/VEGF and the angiogenic response. Semin Perinatol 2000; 24:75-78.
56. Ferrara N, Carver-Moore K, Chen H et al. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 1996; 380:439-442.
57. Carmeliet P, Ferreira V, Breier G et al. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 1996; 380:435-9.
58. Fong GH, Rossant J, Gertsenstein M et al. Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 1995; 376:66-70.
59. Shalaby F, Rossant J, Yamaguchi TP et al. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 1995; 376:62-66.
60. Bauters C, Asahara T, Zheng LP et al. Physiological assessment of augmented vascularity induced by VEGF in ischemic rabbit hindlimb. Am J Physiol 1994; 267:H1263-1271.
61. Takeshita S, Zheng LP, Brogi E et al. Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model. J Clin Invest 1994; 93:662-670.
62. Pearlman JD, Hibberd MG, Chuang ML et al. Magnetic resonance mapping demonstrates benefits of VEGF-induced myocardial angiogenesis. Nat Med 1995; 1:1085-1089.
63. Rosenstein JM, Mani N, Silverman WF et al. Patterns of brain angiogenesis after vascular endothelial growth factor administration in vivo and in vivo. Proc Natl Acad Sci USA 1998; 95:7086-7091.
64. Springer ML, Chen AS, Kraft PE et al. VEGF gene delivery to muscle: potential role for vasculogenesis in adults. Mol Cell 1998; 2:549-558.
65. Kasselman LJ, Ransohoff RM, Cai N et al. Vascular endothelial growth factor (VEGF)-mediated inflammation precedes angiogenesis in adult rat brain. Soc Nsci Abstr 2002; in press.
66. Proescholdt MA, Heiss JD, Walbridge S et al. Vascular endothelial growth factor (VEGF) modulates vascular permeability and inflammation in rat brain. J Neuropathol Exp Neurol 1999; 58:613-627.
67. Carmeliet P. VEGF gene therapy: stimulating angiogenesis or angioma-genesis? Nat Med 2000; 6:1102-1103.
68. Dobrogowska A, Lossinsky AS, Tarnawski M et al. Increased blood-brain barrier permeability and endothelial abnormalities induced by vascular endothelial growth factor. J Neurocytol 1998; 27:63-173.
69. Zhao L, Zhang MM, Ng K. Effects of vascular permeability factor on the permeability of cultured endothelial cells from brain capillaries. J Cardiovasc Pharmacol 1998; 32:1-4.
70. Kaner RJ, Ladetto JV, Singh R et al. Lung overexpression of the vascular endothelial growth factor gene induces pulmonary edema. Am J Respir Cell MolBiol 2000; 22:657-664.
71. Thurston G, Rudge JS, Ioffe E et al. Angiopoietin-1 protects the adult vasculature against plasma leakage. Nat Med 2000; 6:460-463.
72. Kovacs Z, Ikezaki K, Samoto K et al. VEGF and flt: expression time kinetics in rat brain infarct. Stroke 1996; 27:1865-1873.
73. Hayashi T, Abe K, Suzuki H et al. Rapid induction of vascular endothelial growth factor gene expression after transient middle cerebral artery occlusion in rats. Stroke 1997; 28:2039-2044.
74. Cobbs CS, Chen J, Greenberg DA et al. Vascular endothelial growth factor expression in transient focal cerebral ischemia in the rat. Neurosci Lett 1998; 249:79-82.
75. Issa R, Krupinski J, Bujny T et al. Vascular endothelial growth factor and its receptor, KDR, in human brain tissue after ischeamic stroke. Lab Invest 1999; 79:417-425.
76. Lee M-Y, Ju W-K, Cha J-H et al. Expression of vascular endothelial growth factor mRNA following transient forebrain ischemia in rats. Neurosci Lett 1999; 265:107-110.
77. Pichiule P, Chavez JC, Xu K et al. Vascular endothelial growth factor upregulation in transient global ischemia induced by cardiac arrest and resuscitation in rat brain. Brain Res Mol Brain Res 1999; 74:83-90.
78. Plate KH, Beck H, Danner S et al. Cell type specific upregulation of vascular endothelial growth factor in an MCA-occlusion model of cerebral infarct. J Neuropathol Exp Neurol 1999; 58:654-666.
79. Lin TN, Wang CK, Cheung WM et al. Induction of angiopoietin and tie receptor mRNA expression after cerebral ischemia-reperfusion. J Cereb Blood Flow Metab 2000; 20:387-395.
80. Chiarugi V, Magnelli L, Chiarugi A et al. Hypoxia induced pivotal tumor angiogenesis control factors including p53, vascular endothelial growth factor and the NFKB-dependent inducible nitric oxide synthase and cyclo-oxygenase-2. J Cancer Res Clin Oncol 1999; 125:525-528.
81. El Awad B, Kreft B, Wolber EM et al. Hypoxia and interleukin-1 stimulate vascular endothelial growth factor production in human proximal tubular cells. Kidney Intl 2000; 58:43-50.
82. Tsuzuki Y, Fukumura D, Oosthuyse B et al. Vascular endothelial growth factor (VEGF) modulation by targeting hypoxia-inducible factor-10-hypoxia response element-VEGF cascade differentially regulates vascular response and growth rate in tumors. Cancer Res 2000; 60:6248-6252.
83. Yuan HT, Yang SP, Woolf AS. Hypoxia up-regulates angiopoietin-2, a Tie-2 ligand, in mouse mesangial cells. Kidney Int 2000; 58:1912-1919.
84. Bergeron M, Yu AY, Solway KE et al. Induction of hypoxia-inducible factor-1 (HIF-1) and its target genes following focal ischaemia in rat brain. Eur J Neurosci 1999; 11:4159-4170.
85. Hossmann KA. The hypoxic brain. Insights from ischemia research. Adv Exp Med Biol 1999; 474:155-169.
86. Jander S, Schroeter M, Peters O et al. Cortical spreading depression induces proinflammatory cytokine gene expression in the rat brain. J Cereb Blood Flow Metab 2001; 21:218-225.
87. Scharfman HE, Goodman JH, Sollas AL et al. Spontaneous limbic seizures after intrahippocampal infusion of brain-derived neurotrophic factor. Exp Neurol 2002; 174:201-214.
88. Croll SD, Goodman JH, Sollas A et al. Vascular endothelial growth factor (VEGF) is upregulated after pilocarpine-induced seizures in rats. Soc Nsci Abs 2000; in press.
89. Sirevaag AM, Greenough WT. Differential rearing effects on rat visual cortex synapses. III. Neuronal and glial nuclei, boutons, dendrites and capillaries. Brain Res 1987; 424:320-332.
90. Carmeliet P, Storkebaum E. Vascular and neuronal effects of VEGF in the nervous system: implications for neurological disorders. Semin Cell Dev Biol 2002; 13:39-53.
91. Ogunshola OO, Antic A, Donoghue MJ et al. Paracrine and autocrine functions of neuronal vascular endothelial growth factor (VEGF) in the central nervous system. J Biol Chem 2002; 277:11410-11415.
92. Hayashi T, Abe K, Itoyama Y. Reduction of ischemic damage by application of vascular endothelial growth factor in rat brain after transient ischemia. J Cereb Blood Flow Metab 1998; 18:887-895.
93. Jin K, Mao XO, Batteur SP et al. Caspase-3 and the regulation of hypoxic neuronal death by vascular endothelial growth factor. Neuroscience 2001; 108:351-358.
94. Yourey PA, Gohari S, Su JL et al. Vascular endothelial cell growth factors promote the in vivo development of rat photoreceptor cells. J Neurosci 2000; 20:6781-6788.
95. Robinson GS, Ju M, Shih SC et al. Nonvascular role for VEGF: VEGFR-1, 2 activity is critical for neural retinal development. FASEB J 2001; 15:1215-1217.
96. Hobson MI, Green CJ, Terenghi G. VEGF enhances intraneural angiogenesis and improves nerve regeneration after axotomy. J Anat 2000; 197:591-605.
97. Schratzberger P, Schratzberger G, Silver M et al. Favorable effect of VEGF gene transfer on ischemic peripheral neuropathy. Nat Med 2000; 6:405-413.
98. Oosthuyse B, Moons L, Storkebaum E et al. Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration. Nat Genet 2001; 28:131-138.
99. Matsuzaki H, Tamatani M, Yamaguchi A et al. Vascular endothelial growth factor rescues hippocampal neurons from glutamate-induced toxicity: signal transduction cascades. FASEB J 2001; 15:1218-1220.
100. Mazure NM, Chen EY, Laderoute KR et al. Induction of vascular endothelial growth factor by hypoxia is modulated by a phosphatidylinositol 3-kinase/Akt signaling pathway in Ha-ras-transformed cells through a hypoxia-inducible factor-1 transcriptional element. Blood 1997; 90:3322-3331.
101. Gerber HP, McMurtrey A, Kowalski J et al. Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation. J Biol Chem 1998; 273:30336-30343.
102. Wick A, Wick W, Waltenberger J et al. Neuroprotection by hypoxic preconditioning requires sequential activation of vascular endothelial growth factor receptor and Akt. J Neurosci 2002; 22:6401-6407.
103. Bagnard D, Vaillant C, Khuth ST et al. Semaphorin 3A-vascular endothelial growth factor-165 balance mediates migration and apoptosis of neural progenitor cells by the recruitment of shared receptor. J Neurosci 2001; 21:3332-3341.
104. Li J, Perrella MA, Tsai JC et al. Induction of vascular endothelial growth factor gene expression by interleukin-1 beta in rat aortic smooth muscle cells. J Biol Chem 1995; 270:308-312.
105. Ryuto M, Ono M, Izumi H et al. Induction of vascular endothelial growth factor by tumor necrosis factor alpha in human glioma cells. Possible roles of SP-1. J Biol Chem 1996; 271:28220-28228.
106. Jung YD, Liu W, Reinmuth N et al. Vascular endothelial growth factor is upregulated by interleukin-1 beta in human vascular smooth muscle cells via the P38 mitogen-activated protein kinase pathway. Angiogenesis 2001; 4:155-162.
107. Shandra AA, Godlevsky LS, Vastyanov RS et al. The role of TNF-alpha in amygdala kindled rats. Neurosci Res 2002; 42:147-153.
108. Zhang ZG, Zhang L, Jiang Q et al. VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain. Clin Invest 2000; 106:829-838.
109. van Bruggen N, Thibodeaux H, Palmer JT et al. VEGF antagonism reduces edema formation and tissue damage after ischemia/reperfusion injury in the mouse brain. J Clin Invest 1999; 104:1613-1620.
110. Baik EJ, Kim EJ, Lee SH et al. Cyclooxygenase-2 selective inhibitors aggravate kainic acid induced seizure and neuronal cell death in the hippocampus. Brain Res 1999; 843:118-129.